The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer (Q28190201)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: October 2001)
edit
Language Label Description Also known as
English
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer
scientific article (publication date: October 2001)

    Statements

    The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer (English)
    0 references
    D W Rusnak
    0 references
    K Affleck
    0 references
    S G Cockerill
    0 references
    C Stubberfield
    0 references
    R Harris
    0 references
    M Page
    0 references
    K J Smith
    0 references
    S B Guntrip
    0 references
    M C Carter
    0 references
    R J Shaw
    0 references
    A Jowett
    0 references
    J Stables
    0 references
    P Topley
    0 references
    E R Wood
    0 references
    P S Brignola
    0 references
    S H Kadwell
    0 references
    B R Reep
    0 references
    R J Mullin
    0 references
    K J Alligood
    0 references
    B R Keith
    0 references
    R M Crosby
    0 references
    D M Murray
    0 references
    W B Knight
    0 references
    T M Gilmer
    0 references
    K Lackey
    0 references
    1 October 2001
    0 references
    61
    0 references
    19
    0 references
    7196-203
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit